cdp 840 has been researched along with Long QT Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ball, RG; Blouin, M; Boulet, L; Côté, B; Ducharme, Y; Frenette, R; Friesen, RW; Girard, M; Girard, Y; Guay, D; Huang, Z; Jones, TR; Laliberté, F; Lynch, JJ; Mancini, J; Martins, E; Masson, P; Muise, E; Pon, DJ; Siegl, PK; Styhler, A; Tsou, NN; Turner, MJ; Young, RN | 1 |
1 other study(ies) available for cdp 840 and Long QT Syndrome
| Article | Year |
|---|---|
Optimization of a tertiary alcohol series of phosphodiesterase-4 (PDE4) inhibitors: structure-activity relationship related to PDE4 inhibition and human ether-a-go-go related gene potassium channel binding affinity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Alcohols; Animals; Bronchoconstriction; Crystallography, X-Ray; Cyclic N-Oxides; Cyclic Nucleotide Phosphodiesterases, Type 4; Dogs; Electrocardiography; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; Humans; In Vitro Techniques; Long QT Syndrome; Phosphodiesterase Inhibitors; Potassium Channels; Potassium Channels, Voltage-Gated; Protein Binding; Pyridines; Rats; Saimiri; Sheep; Stereoisomerism; Structure-Activity Relationship; Tumor Necrosis Factor-alpha; Vomiting | 2003 |